Comments for Clinuvel Pharma (CUV.AX) (CLVLY.PK): Corporate Interview at http://www.biomedreports.com , comment 1 to 1 out of 1 comments http://www.biomedreports.com Thu, 24 May 2012 21:04:56 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/200908246695/clinuvel-pharma-cuvax-clvlypk-corporate-interview.html#comment-694 Greetings Mike Rabe, Excellent question about the topical administration method and what happened with the London trial. This has been a question that many have had for some time and the whole thing is definitely a bit of an enigma. It seems that either the early results of their testing was a complete washout or it worked too well and they decided to slow things down a bit. If only Clinuvel would give a straight answer about this. News about strong efficacy of a Transdermal Technologies based lotion version would be a big boon for the value of Clinuvel! Cheers, [url=http://melanotan.org/]melanotan - afamelanotide[/url] - melanotan - afamelanotide Mon, 24 Aug 2009 11:35:17 +0100